© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A new long-acting injectables HIV drug shows promise in monkey study.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
HIV advocate Lepena Reid confronts weight gain.
Some HIV meds are linked to weight gain, but we don’t yet know why.
The reasons for gaining weight aren’t always clear.
Aging with HIV won’t slow down Robert Gillum.
Overweight and obesity are linked to a host of health problems.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
A recent study links simplified HIV treatment with a greater risk of inflammation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
